Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.
The Rutherford Cancer Centres and Elekta are bringing the next generation of personalised adaptive radiotherapy technology to oncology centres across the UK, with the new MR-linac Elekta Unity now available at the Rutherford Cancer Centre North West in Liverpool.
Interested in finding out more about innovative work happening in the oncology field? Take a look at these resources and updates for healthcare professionals on the latest research projects and clinical collaborations:
Proton Therapy in the UK- a 2018 research article in the International Journal of Cancer Treatment; written by Karol Sikora, Chief Medical Officer and John Pettingell, Chief Physicist at Rutherford Health Plc. This article discusses the evolution of precision radiotherapy in the UK.
Sikora on oncology (for Medscape) - Professor Karol Sikora is Chief Medical Officer and Co-founder of the Rutherford Cancer Centres and Rutherford Health plc. His perspective section on Medscape explores cancer care for children, Covid-19 and cancer assessments and more.
Clinical Trials at the Rutherford - Rutherford Cancer Centres is working in collaboration with Panthera Biopartners to help oncology patients access opportunities to take part in clinical research and trials. Find out more by visiting our Clinical Trials at the Rutherford page.